OTC Markets OTCPK - Delayed Quote USD

VMS Rehab Systems, Inc. (VRSYF)

0.0000 0.0000 (0.00%)
At close: February 26 at 11:34 AM EST
Loading Chart for VRSYF
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0001
  • Volume 13,000
  • Avg. Volume 0
  • Market Cap (intraday) 1,561
  • Beta (5Y Monthly) 77.95
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 0.1410
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

VMS Rehab Systems, Inc. engages in generic drug and home healthcare businesses. It develops and tests generic tadalafil products. The company also sells orthopedic wedge seat cushions for relieving the discomfort and/or pain caused by other lower body medical issues, including pilonidal disease, piles disease, and hemorrhoids to home healthcare retail networks in Canada. VMS Rehab Systems, Inc. was founded in 1998 and is based in Ottawa, Canada.

www.vmsrehabsystemsinc.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VRSYF

Performance Overview: VRSYF

Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VRSYF
99.00%
S&P 500
10.64%

1-Year Return

VRSYF
99.00%
S&P 500
25.49%

3-Year Return

VRSYF
99.93%
S&P 500
25.53%

5-Year Return

VRSYF
99.98%
S&P 500
89.24%

Compare To: VRSYF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VRSYF

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    64.78%

  • Return on Assets (ttm)

    -320.44%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    76.17k

  • Net Income Avi to Common (ttm)

    49.34k

  • Diluted EPS (ttm)

    0.1410

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -218.91k

Research Analysis: VRSYF

Company Insights: VRSYF

Research Reports: VRSYF